Copyright
©The Author(s) 2019.
World J Gastroenterol. Aug 21, 2019; 25(31): 4468-4480
Published online Aug 21, 2019. doi: 10.3748/wjg.v25.i31.4468
Published online Aug 21, 2019. doi: 10.3748/wjg.v25.i31.4468
Figure 3 MiR-194 inhibits the proliferation of hepatic stellate cells.
A: LX2 cells were treated with OV-miR-194/si-miR-194±TGF-β1. The CCK8 assay showed the proliferation of LX2 cells; B: The cell cycle was analyzed by flow cytometry; C: The mRNA expression of cyclin D1 analyzed by qPCR; D: The protein expression of cyclin D1 analyzed by Western blot. aP < 0.05 vs the con group; bP < 0.05 vs the TGF-β1 + OV-miR-NC group; cP < 0.05 vs the TGF-β1 + si-NC group.
- Citation: Wu JC, Chen R, Luo X, Li ZH, Luo SZ, Xu MY. MicroRNA-194 inactivates hepatic stellate cells and alleviates liver fibrosis by inhibiting AKT2. World J Gastroenterol 2019; 25(31): 4468-4480
- URL: https://www.wjgnet.com/1007-9327/full/v25/i31/4468.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i31.4468